Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check2 days agoChange DetectedUpdates to the study page include date-stamped additions on 2026-03-12 and 2026-03-13 and deletions on 2026-03-05 and 2026-03-06.SummaryDifference0.0%

- Check9 days agoChange DetectedUniversity of Michigan Rogel Cancer Center was added as a participating site and University of Michigan Comprehensive Cancer Center was removed; the record was updated to Revision: v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. No study details or user-facing content were changed.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedUI/text updates were made, including a glossary toggle, updated QC/posted timestamps, No FEAR Act labeling changes, and a revision note to v3.4.0. These are administrative changes and do not affect the study data or outcomes.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.3.4; the previous Revision: v3.3.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.